Rafferty Asset Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.65M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.11M | Sell |
|
|||||
|
2023
Q1 | $2M | Buy |
|
|||||
|
2022
Q4 | $2.44M | Buy |
|
|||||
|
2022
Q3 | $1.45M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $1.73M | Buy |
|
|||||
|
2021
Q3 | $1.53M | Buy |
|
|||||
|
2021
Q2 | $1.59M | Sell |
|
|||||
|
2021
Q1 | $3M | Buy |
|
|||||
|
2020
Q4 | $827K | Sell |
|
|||||
|
2020
Q3 | $1.44M | Buy |
|
|||||
|
2020
Q2 | $274K | Buy |
|